The biological seed treatment market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market has been growing at a significant rate due to the increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers on product development such as compatible combinations of biological and chemical components is expected to drive the growth of the market over the next five years.
Companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group (Switzerland), Corteva Agriscience (US) have been focusing on technological innovations in seed inoculation and patent registrations for new product launches to strengthen their market base in the concerned market. Apart from these companies, other biological seed treatment companies include Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), and Incotec (Netherlands), which have been strengthening their market position through product launches and distribution & technology agreements.
Expansions were the most used strategy by the key players in the seed treatment market. R&D centers/innovation labs were inaugurated by companies such as BASF SE (Germany), Syngenta Group (Switzerland), Koppert Biological Systems (Netherlands), and Incotec (Netherlands). Due to the overall growing demand for biostimulants and microbial-based technologies, companies such as BASF SE (Germany), Incotec (Netherlands), Valent BioSciences (US), and Italpollina (Italy) have invested in the upgradation & expansion of their existing facilities or establishment of new manufacturing facilities.
Bayer AG (Germany) is one of the active players in the biological seed treatment market. A considerable amount of Bayer revenue goes into research & development activities to offer innovative products and practices to the farming community across the world. Bayer has successfully pushed products into the market through its farmer engagement programs. Bayer has made significant investments in the acquisition of seed treatment technology providers and established research collaborations for the development of microbial seed treatment products through its SeedGrowth business unit. The acquisition of Monsanto (US) in 2018, has been a big milestone in Bayer’s history of developments, which has allowed the company to enhance its research on new technologies for improving the available solutions for crop protection. In 2018, the company received marketing authorization in many countries for new mixtures and formulations, which will further strengthen its global presence. It has also expanded its global presence, clubbed with high levels of investments in R&D activities to serve its customers with innovative products in biological seed treatment market.
Syngenta Group (Switzerland) has been a leading player in the agricultural industry by offering diverse innovative solutions to the market place. Through its product investment & partnership approach, the company focuses on delivering sustainable solutions through its seed treatment technology in order to capitalize on a growing market demand for biological solutions, and progress to a formidable position at the preliminary stage of the market. It has a strong brand image and early mover advantage due to the introduction of Clariva, the first biological nematicide for seed treatment. In October 2020, Syngenta Group announced the acquisition of Valagro (Italy), a leading Biologicals company, through its business unit Syngenta Crop Protection. Through this strategy, Syngenta Crop Protection positions itself as one of the key global companies to shape the rapidly growing biologicals market, which is set to nearly double in size over the next five years.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
